Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
Status:
Completed
Trial end date:
2015-05-31
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine whether the combination of the bile acid TUDCA,
and doxycycline will slow the progression of familial and senile amyloidosis.